2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
Merck KGaA, Darmstadt, Germany Signs Long-Term Renewable Energy Contract for South Korea Sites
20-year Power Purchase Agreement with SK Innovation E&S to add 16 MW of renewable electricity capacity starting in December 2027Supports...
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods...
VSee Health Secures Three-Year Platform Services Agreement with the Region’s Sole Level 1 Trauma Center and Academic Health System
Volume-based contract with no revenue ceiling covers virtual urgent care and behavioral health across more than 100 facilities; services commence...
Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder
Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder. FRAMINGHAM, MA / ACCESS Newswire...
AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica
Collaboration Advances Local Regulatory Pathway for AI-Enabled ECG Diagnostics to Address the Growing Cardiovascular Disease Burden in Jamaica TORONTO, ON...
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections
New FDA feedback confirms clinical pathway for fixed multi-phage cocktail BX011, expanding development into diabetic foot infections (DFI) and unlocking...
24/7 Market News- Kraig Labs’ Spider Silk Breakthrough Poised to Rival Nylon’s 1939 Revolution
The Dawn of a New Fiber EraDENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated...
Aligos Therapeutics to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company...
InStride Health Announces Key Leadership Additions, Promotions to Enhance Payer Engagement, Technical Enablement, and Clinical Operations
With new and elevated leaders, InStride is poised to scale its care model while maintaining its differentiated specialty careBOSTON, Nov....
TELA Bio to Announce Third Quarter 2025 Financial Results
MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company...
Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer
Highlights Broad Development Potential of Proprietary Portfolio Targeting FABPsSOLANA BEACH, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc....
CVRx to Present at the Jefferies Global Healthcare Conference in London
MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing,...
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Nov....
Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights
— Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7% — Third quarter...
Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year
Company Achieves Third Consecutive Quarter of Revenue Growth Revenue Increase of Approximately 32% Sequentially and 28% Year-Over-Year Driven by New...
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th
MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company...
Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association’s Sessions 2025 in New Orleans
Study results further differentiate sotagliflozin from SGLT inhibitors and cardiac myosin inhibitorsTHE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) --...
Equillium to Participate in Upcoming Investor Conferences
LA JOLLA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep...
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin...
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on...